InvestorsHub on MSN
POET Technologies Shares Climb on New AI-Focused Partnership with QCi
POET Technologies Inc. (NASDAQ:POET) shares rose 2.3% in premarket trading Tuesday after the company announced a strategic ...
G/Lane, TFLN modulator-based innovation to play a key role in the future of computingSAN JOSE, Calif. and HOBOKEN, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the ...
Under the agreement, QCi will integrate its high-performance 400G/Lane modulators with POET’s Optical Interposer platform technology. The resulting engine is designed to provide data-transfer speeds ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chiplet™ platform, today announced the launch of its groundbreaking 110 GHz Low Vπ Intensity Modulator, featuring industry-standard ...
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...
Modulator therapy does not appear to affect the magnitude of lung function impairment or recovery pattern during pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback